pioglitazone has been researched along with malondialdehyde in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (37.50) | 29.6817 |
2010's | 14 (58.33) | 24.3611 |
2020's | 1 (4.17) | 2.80 |
Authors | Studies |
---|---|
Kohno, M; Miyatake, A; Mizushige, K; Murakami, K; Noma, T; Ohmori, K; Tsuji, T | 1 |
Pathan, AR; Ramarao, P; Sonkusare, SK; Viswanad, B | 1 |
Li, XP; Liu, LP; Shen, XQ; Zhang, M; Zhao, S; Zhou, SH | 1 |
Hsiao, PJ; Hsieh, TJ; Hung, WW; Kuo, KK; Shin, SJ; Tsai, KB; Yang, CH; Yu, ML | 1 |
Hirasawa, Y; Ito, M; Kawasaki, Y; Kyuki, K; Matsui, Y; Nagamatsu, T; Sakai, T; Toyoshi, T; Yabuki, SY; Yamane, K | 1 |
Kaundal, RK; Kumar, P; More, S; Sharma, SS | 1 |
Kaundal, RK; Sharma, R; Sharma, SS | 1 |
Iyer, S; Kaundal, RK; Kumar, A; Sharma, SS | 1 |
Asl, NA; Azar, AN; Estakhri, R; Haghjou, AG; Hajipour, B; Somi, MH; Vatankhah, AM; Zade, MN | 1 |
Cheng, WM; Hu, XY; Li, J; Lu, YX; Sun, YX; Wang, LY; Zhang, Q | 1 |
Hayashi, S; Taguchi, A | 1 |
Alarcon-Aguilar, FJ; Almanza-Perez, JC; Angeles-Mejia, S; Banderas-Dorantes, TR; Blancas-Flores, G; Diaz-Flores, M; Fortis-Barrera, A; Gomez, J; Jasso, I; Roman-Ramos, R; Zamilpa-Alvarez, A | 1 |
Chen, XM; Liu, S; Yang, CQ; Zhao, JS; Zhu, FS | 1 |
Kong, X; Li, FX; Su, Q; Wu, HB; Zhang, DY; Zhang, Y | 1 |
Han, S; Hwang, J; Kim, H; Lim, C; Min, S; Nahm, SF; Park, K; Park, S | 1 |
Byrav D S, P; Chakrabarti, A; Khanduja, KL; Medhi, B; Prakash, A; Vaiphei, K | 1 |
Amniattalab, A; Hobbenaghi, R; Khoramjouy, M; Malekinejad, H | 1 |
El-Gowelli, HM; El-Gowilly, SM; Helmy, MM | 1 |
Abd El-Haleim, EA; Bahgat, AK; Saleh, S | 1 |
Feng, J; Lu, C; Ma, J; Sun, L; Wang, D; Wang, L; Xu, T; Yao, L; Yuan, Q | 1 |
Abdel-Rahman, N; Eissa, LA; Eraky, SM | 1 |
Abdelaziz, RR; Abdelhamid, AM; Salem, HAA | 1 |
Divac, N; Jovanović, GB; Kekić, D; Medić, B; Prostran, M; Radenković, M; Rovčanin, B; Škodrić, SR; Stojanović, M; Stojanović, R; Vujović, KS | 1 |
Abdelrahman, AM; El-Tahawy, NF; Ibrahim, SA; Mohamed, MZ | 1 |
1 trial(s) available for pioglitazone and malondialdehyde
Article | Year |
---|---|
[Study of MDA-LDL by pioglitazone and pitavastatin in patients with type 2 diabetes].
Topics: Aged; Arteriosclerosis; Biomarkers; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Disease Progression; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pioglitazone; Quinolines; Risk Factors; Thiazolidinediones | 2011 |
23 other study(ies) available for pioglitazone and malondialdehyde
Article | Year |
---|---|
Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat.
Topics: Animals; Blood Glucose; Collagen; Diabetes Mellitus, Type 2; Diastole; Echocardiography, Doppler; Hemodynamics; Hypoglycemic Agents; Insulin; Kinetics; Lipids; Male; Malondialdehyde; Oxidative Stress; Pioglitazone; Prediabetic State; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Thiazoles; Thiazolidinediones; Thiobarbituric Acid Reactive Substances; Ventricular Dysfunction, Left | 2001 |
Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats.
Topics: Administration, Oral; Aging; Animals; Antibiotics, Antineoplastic; Brain Chemistry; Cognition; Dementia; Diabetes Complications; Dose-Response Relationship, Drug; Energy Metabolism; Glucose; Glutathione; Hypoglycemic Agents; Male; Malondialdehyde; Maze Learning; Memory Disorders; Oxidative Stress; Pioglitazone; Rats; Rats, Wistar; Streptozocin; Thiazolidinediones; Time Factors | 2006 |
Pioglitazone can downregulate bone morphogenetic protein-2 expression induced by high glucose in human umbilical vein endothelial cells.
Topics: Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Down-Regulation; Endothelial Cells; Endothelium, Vascular; Glucose; Humans; Hypoglycemic Agents; Malondialdehyde; NF-kappa B; Pioglitazone; Superoxide Dismutase; Thiazolidinediones; Transforming Growth Factor beta; Umbilical Veins | 2008 |
Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet.
Topics: Animals; Antioxidants; Dietary Fats; DNA Damage; DNA Glycosylases; DNA Repair; Fatty Liver; Guanosine; Hepatocytes; Hypoglycemic Agents; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Oxidative Stress; Pioglitazone; Superoxide Dismutase; Superoxide Dismutase-1; Thiazolidinediones | 2008 |
Pioglitazone improves obesity type diabetic nephropathy: relation to the mitigation of renal oxidative reaction.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Blood Glucose; Cholesterol; Cystatin C; Cystatins; Diabetic Nephropathies; Glycated Hemoglobin; Guanine; Hypoglycemic Agents; Insulin; Kidney; Malondialdehyde; Obesity; Oxidation-Reduction; Phospholipids; Pioglitazone; Rats; Rats, Zucker; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazolidinediones; Transforming Growth Factor beta; Triglycerides | 2008 |
Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease.
Topics: Administration, Oral; Animals; Avoidance Learning; Cognition; Discrimination Learning; Disease Models, Animal; Exploratory Behavior; Glutathione; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Memory; MPTP Poisoning; Pioglitazone; Rats; Rats, Wistar; Spatial Behavior; Spectrophotometry; Substantia Nigra; Thiazolidinediones | 2009 |
Amelioration of pulmonary dysfunction and neutrophilic inflammation by PPAR gamma agonist in LPS-exposed guinea pigs.
Topics: Administration, Inhalation; Animals; Bronchoalveolar Lavage Fluid; Escherichia coli Proteins; Guinea Pigs; Leukocyte Count; Lipopolysaccharides; Lung; Lung Diseases; Male; Malondialdehyde; Neutrophils; Oxidative Stress; Peroxidase; Phosphodiesterase Inhibitors; Pioglitazone; Plethysmography, Whole Body; Pneumonia; PPAR gamma; Rolipram; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2009 |
Protective effects of pioglitazone against global cerebral ischemic-reperfusion injury in gerbils.
Topics: Animals; Brain Ischemia; Disease Models, Animal; DNA Fragmentation; Gerbillinae; Hippocampus; Hyperkinesis; Hypoglycemic Agents; In Situ Nick-End Labeling; Male; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Pioglitazone; Reperfusion Injury; Thiazolidinediones | 2009 |
Pioglitazone attenuates ischemia/reperfusion-induced liver injury in rats.
Topics: Animals; Anti-Bacterial Agents; Glutathione Peroxidase; Liver; Male; Malondialdehyde; Pioglitazone; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase; Thiazolidinediones | 2009 |
Antidiabetic effects of total flavonoids from Litsea Coreana leve on fat-fed, streptozotocin-induced type 2 diabetic rats.
Topics: Animals; Antioxidants; Body Weight; C-Reactive Protein; Diabetes Mellitus, Experimental; Dietary Fats; Flavonoids; Hypoglycemic Agents; Insulin Resistance; Islets of Langerhans; Lipids; Litsea; Liver; Male; Malondialdehyde; Phytotherapy; Pioglitazone; Plant Extracts; Plant Leaves; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thiazolidinediones | 2010 |
Antioxidant and anti-inflammatory effects of a hypoglycemic fraction from Cucurbita ficifolia Bouché in streptozotocin-induced diabetes mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Cucurbita; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fruit; Glutathione; Hypoglycemic Agents; Inflammation Mediators; Inositol; Liver; Male; Malondialdehyde; Mice; Mice, Inbred Strains; Oxidative Stress; Phytotherapy; Pioglitazone; Plant Extracts; Thiazolidinediones | 2012 |
Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
Topics: Alanine Transaminase; Animals; Cyclooxygenase 2; Fatty Liver; Glutathione Peroxidase; Male; Malondialdehyde; NF-kappa B; Pioglitazone; PPAR gamma; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Superoxide Dismutase; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2012 |
Combination therapy with losartan and pioglitazone additively reduces renal oxidative and nitrative stress induced by chronic high fat, sucrose, and sodium intake.
Topics: Animals; Body Weight; Diet, High-Fat; Dietary Sucrose; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Enzymologic; Immunohistochemistry; Kidney; Losartan; Male; Malondialdehyde; NADPH Oxidases; Nitrosation; Oxidation-Reduction; Oxidative Stress; Pioglitazone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium, Dietary; Superoxide Dismutase; Thiazolidinediones; Tyrosine | 2012 |
A peroxisome proliferator-activated receptor gamma agonist attenuates neurological deficits following spinal cord ischemia in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Infarction; Inflammation; Male; Malondialdehyde; Microglia; Motor Activity; Motor Neurons; Neuroprotective Agents; Oxidative Stress; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Ischemia; Thiazolidinediones; Time Factors | 2014 |
Comparative evaluation of different doses of PPAR-γ agonist alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Malondialdehyde; Peroxidase; Pioglitazone; PPAR gamma; Rats; Sulfasalazine; Thiazolidinediones; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2013 |
Atorvastatin attenuates the paraquat-induced pulmonary inflammation via PPARγ receptors: a new indication for atorvastatin.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Heptanoic Acids; Herbicides; Interleukin-6; Lung; Male; Malondialdehyde; Nitric Oxide; Paraquat; Peroxidase; Pioglitazone; Pneumonia; PPAR gamma; Pyrroles; Rats, Wistar; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Loss | 2014 |
Pioglitazone ameliorates methotrexate-induced renal endothelial dysfunction via amending detrimental changes in some antioxidant parameters, systemic cytokines and Fas production.
Topics: Animals; Antioxidants; Cytokines; fas Receptor; Glutathione; Kidney; Kidney Diseases; Male; Malondialdehyde; Methotrexate; Oxidative Stress; Pioglitazone; Rats; Rats, Wistar; Thiazolidinediones | 2015 |
Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Topics: Adiponectin; Adipose Tissue; Animals; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Fenofibrate; Fructose; Gene Expression Regulation; Glutathione; Homeostasis; Insulin; Leptin; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Pioglitazone; PPAR alpha; PPAR gamma; Rats; Rats, Wistar; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
Pioglitazone, a Peroxisome Proliferator-Activated Receptor x03B3; Agonist, Ameliorates Chronic Kidney Disease by Enhancing Antioxidative Capacity and Attenuating Angiogenesis in the Kidney of a 5/6 Nephrectomized Rat Model.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Down-Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Malondialdehyde; Neovascularization, Physiologic; Nephrectomy; Nitric Oxide; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Superoxide Dismutase; Thiazolidinediones; Vascular Endothelial Growth Factor A | 2016 |
Modulating effects of omega-3 fatty acids and pioglitazone combination on insulin resistance through toll-like receptor 4 in type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Cholesterol; Combined Modality Therapy; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Down-Regulation; Fatty Acids, Omega-3; Insulin Resistance; Male; Malondialdehyde; Pioglitazone; Rats; Rats, Sprague-Dawley; Streptozocin; Toll-Like Receptor 4 | 2018 |
Vildagliptin/pioglitazone combination improved the overall glycemic control in type I diabetic rats.
Topics: Adamantane; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Glucagon; Glutathione; Glycated Hemoglobin; Insulin; Male; Malondialdehyde; Nitric Oxide; Nitriles; Pancreas; Pioglitazone; Pyrrolidines; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase; Thiazolidinediones; Vildagliptin | 2018 |
Pioglitazone attenuates kidney injury in an experimental model of gentamicin-induced nephrotoxicity in rats.
Topics: Animals; Anti-Bacterial Agents; Catalase; Creatinine; Gentamicins; Hypoglycemic Agents; Kidney; Kidney Diseases; Male; Malondialdehyde; Oxidative Stress; Pioglitazone; Protective Agents; Rats; Rats, Wistar; Superoxide Dismutase | 2019 |
Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats.
Topics: Actins; Animals; Bezafibrate; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Liver Function Tests; Male; Malondialdehyde; Nitrites; Pioglitazone; Rats; Thioacetamide | 2021 |